Immunogenicity assessment is a critical aspect of the development of biotherapeutics, which are drugs derived from biological sources, such as proteins or antibodies. This assessment involves ...

Product-related and patient-related factors affecting the immunogenicity of biopharmaceuticals are outlined. ADA: Anti-drug antibody; APC: Antigen-presenting cell; BCR: B-cell receptor ...

The purpose of this analysis was to examine the immunogenicity of panitumumab and to evaluate the effect of anti-panitumumab antibodies on pharmacokinetic and safety profiles in patients with mCRC ...

This whitepaper explores how innovative chromatography solutions can improve aggregate removal while maintaining high product ...

In this interview, Technology Networks spoke with Dr. Sophie Mayle, Dr. Paul Royle and Dr. John Cardone from Bio-Rad's ...

Valneva (VALN) announced results for its Phase 2 clinical trial evaluating the safety and immunogenicity of two different ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today reported further positive Phase 3 data in adolescents for its single-shot chikungunya virus (CHIKV) vaccine, IXCHIQ®, ...

First announced in October 2024, the new Immunogenicity (IgX ... histopathology, antibody discovery, and in vivo studies. Discover how Sapio Sciences can revolutionize your lab operations at ...

CStone, the drug’s developer, previously announced similar deals with various pharmaceutical companies to expand sugemalimab ...